Implications of oncology trial design and uncertainties in efficacy-safety data on health technology assessments

HIGHLIGHTS

  • who: Dario Trapani and colleagues from the European Institute of Oncology, IRCCS, Milan, Italy Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy have published the research work: Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments, in the Journal: (JOURNAL)
  • what: Initially, the authors focused oninternational non-structural barriers in implementing HTA Nations agencies, governmental HTA bodies and Ministries of Health were also consulted. (i.e., structural barriers are those related to a lack of skilled human resources or budget Preparatory research for this paper (DT . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?